Vignard V - Search Results

1

Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.

Gauttier V, Pengam S, Durand J, Biteau K, Mary C, Morello A, Néel M, Porto G, Teppaz G, Thepenier V, Danger R, Vince N, Wilhelm E, Girault I, Abes R, Ruiz C, Trilleaud C, Ralph K, Trombetta ES, Garcia A, Vignard V, Martinet B, Glémain A, Bruneau S, Haspot F, Dehmani S, Duplouye P, Miyasaka M, Labarrière N, Laplaud D, Le Bas-Bernardet S, Blanquart C, Catros V, Gouraud PA, Archambeaud I, Aublé H, Metairie S, Mosnier JF, Costantini D, Blancho G, Conchon S, Vanhove B, Poirier N. Gauttier V, et al. Among authors: vignard v. J Clin Invest. 2020 Nov 2;130(11):6109-6123. doi: 10.1172/JCI135528. J Clin Invest. 2020. PMID: 33074246 Free PMC article.

2

Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.

Godet Y, Desfrançois J, Vignard V, Schadendorf D, Khammari A, Dreno B, Jotereau F, Labarrière N. Godet Y, et al. Among authors: vignard v. Eur J Immunol. 2010 Jun;40(6):1786-94. doi: 10.1002/eji.200940132. Eur J Immunol. 2010. PMID: 20217862 Free article.

3

Overexpression of meloe gene in melanomas is controlled both by specific transcription factors and hypomethylation.

Bobinet M, Vignard V, Florenceau L, Lang F, Labarriere N, Moreau-Aubry A. Bobinet M, et al. Among authors: vignard v. PLoS One. 2013 Sep 25;8(9):e75421. doi: 10.1371/journal.pone.0075421. eCollection 2013. PLoS One. 2013. PMID: 24086527 Free PMC article.

4

MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma.

Vignard V, Labbé M, Marec N, André-Grégoire G, Jouand N, Fonteneau JF, Labarrière N, Fradin D. Vignard V, et al. Cancer Immunol Res. 2020 Feb;8(2):255-267. doi: 10.1158/2326-6066.CIR-19-0522. Epub 2019 Dec 19. Cancer Immunol Res. 2020. PMID: 31857348

5

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.

Simon S, Vignard V, Varey E, Parrot T, Knol AC, Khammari A, Gervois N, Lang F, Dreno B, Labarriere N. Simon S, et al. Among authors: vignard v. Cancer Res. 2017 Dec 15;77(24):7083-7093. doi: 10.1158/0008-5472.CAN-17-1856. Epub 2017 Dec 6. Cancer Res. 2017. PMID: 29212853

6

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features.

Simon S, Wu Z, Cruard J, Vignard V, Fortun A, Khammari A, Dreno B, Lang F, Rulli SJ, Labarriere N. Simon S, et al. Among authors: vignard v. Front Immunol. 2018 Aug 30;9:1962. doi: 10.3389/fimmu.2018.01962. eCollection 2018. Front Immunol. 2018. PMID: 30214446 Free PMC article. Clinical Trial.

7

MELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients.

Bobinet M, Vignard V, Rogel A, Khammari A, Dreno B, Lang F, Labarriere N. Bobinet M, et al. Among authors: vignard v. PLoS One. 2012;7(12):e51716. doi: 10.1371/journal.pone.0051716. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284752 Free PMC article.

8

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.

Godet Y, Moreau-Aubry A, Guilloux Y, Vignard V, Khammari A, Dreno B, Jotereau F, Labarriere N. Godet Y, et al. Among authors: vignard v. J Exp Med. 2008 Oct 27;205(11):2673-82. doi: 10.1084/jem.20081356. Epub 2008 Oct 20. J Exp Med. 2008. PMID: 18936238 Free PMC article.

9

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients.

Dréno B, Khammari A, Fortun A, Vignard V, Saiagh S, Beauvais T, Jouand N, Bercegay S, Simon S, Lang F, Labarrière N. Dréno B, et al. Among authors: vignard v. Cancer Immunol Immunother. 2021 Oct;70(10):3015-3030. doi: 10.1007/s00262-021-02961-0. Epub 2021 Jun 12. Cancer Immunol Immunother. 2021. PMID: 34120214 Free PMC article. Clinical Trial.

10

Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.

Samimi M, Benlalam H, Aumond P, Gaboriaud P, Fradin D, Kervarrec T, Florenceau L, Vignard V, Blom A, Touzé A, Gervois N, Labarriere N. Samimi M, et al. Among authors: vignard v. Cell Immunol. 2019 Oct;344:103961. doi: 10.1016/j.cellimm.2019.103961. Epub 2019 Aug 1. Cell Immunol. 2019. PMID: 31472938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page